Global Substance Abuse Treatment Market is segmented By Treatment Type (Tobacco/Nicotine Addiction Treatment, Drug Abuse Treatment, Other Treatment Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Market Overview
The Global "Substance Abuse Treatment Market" is expected to reach a high CAGR during the forecast period.
The use of prescription or OTC drugs or illegal drugs or alcohol in excessive amounts for purposes other than which they are meant to be used is known as substance abuse. Substance abuse may lead to social, physical, emotional, and job-related problems.
Market Dynamics
Increasing the incidence of drug addiction and raising awareness about substance abuse and its treatment will drive the substance abuse treatment market.
Increasing incidence of drug addiction will drive the substance abuse treatment market
In the previous years, about 270 million people had used psychoactive drugs. Around 35 million people are estimated to be affected by drug use disorders (harmful patterns of drug use or drug dependence). According to the World Drug Report, released by the United Nations Office on Drugs and Crime (UNODC) around 35 million people globally are estimated to suffer from drug use disorders and require treatment services. Drug addiction is a disease that affects the behavior of a person, their brain and leads to an uncontrollable use of an illegal or legal drug or medication. Substances such as nicotine, marijuana, and alcohol also are considered drugs. Drug addiction can start with the practical use of a recreational drug in social situations and may become more frequent. For others, particularly with opioids, drug addiction begins with exposure to prescribed medications or receiving medications from a friend or relative who has been prescribed the medication. The risk of addiction and how fast you become addicted varies by drug. Some drugs, such as opioid painkillers, have a higher risk and cause addiction more quickly than others.
Drug treatment is intended to help addicted people stop compulsive drug use and seeking. Treatment can occur in various settings, many different forms and may last for different time lengths. As drug addiction is a chronic disorder typically characterized by occasional relapses, short-term, one-time treatment is usually insufficient. Sometimes treatment is a long-term process involving regular monitoring and multiple interventions.
Rising awareness about substance abuse and its treatment will drive the substance abuse treatment market
Across the nation, leaders look for new ways to fight the growing addiction epidemic and raise awareness. As essential therapeutic modalities, Prescription drugs classified as controlled dangerous substances are widely accepted in treating various healthcare conditions. For uses other than intended many prescription medications have pleasurable side effects that can appeal to patients to take these drugs. Abuse or misuse of prescription drugs can contribute to addictive behaviors, serious health risks, and potentially death. The National Institute on Drug Abuse (NIDA), other state and local agencies across the country maintain a close watch on trends in drug abuse of prescription drugs.
World Drug Day is on June 26. Its goal is to raise awareness about drug addiction and the issues it can create. The U.N. leads this international cause to educate people about drug use and solve this problem globally. Drug addiction treatment helps people with substance use disorders make a safe and lifelong recovery. While treatment can help, World Drug Day seeks to prevent and manage drug use before addiction, and other problems ever begin.
Legal regulation for treatment products will hamper the substance abuse treatment market
Drug legalization advocates believe that making high-quality drugs widely and cheaply available will eliminate the illegal drug market, price,regulate quality and decrease law costs for enforcement, including incarceration and arrest. If drugs from heroin to marijuana become routinely accessible they predict that governments will spend less money on law enforcement, benefit from a new source of tax revenue, and that drug-related crime will fall, more or less as are alcohol and tobacco.
With a big disadvantage legal marijuana competes with illegal marijuana. Legal marijuana is subjected to taxes to add to its price and regulations. Legal marijuana has shown great innovation in products by the suppliers, including the sale of edibles vaping oils, and THC concentrates (dabs). Both suppliers have increased the potency of their products, adding to their risks. In 2019, in response to the legalization of marijuana in Massachusetts, scientists and a consortium of clinicians released a Statement of Concern expressing their disagreement with how marijuana policy is being shaped across the state.
COVID-19 Impact on Substance Abuse Treatment Market
COVID-19 has affected the healthcare industry. To curb its growth, government-imposed lockdown. People are fearful they will experience occupational effects and negative health from the COVID-19 pandemic. This has seen to affect the substance abuse treatment market as many have stopped manufacturing units.
Market Segmentation Analysis
The tobacco/Nicotine addiction treatment segment will dominate the substance abuse treatment market
Globally, the use of tobacco per year causes more than 7 million deaths. All over the globe if the pattern of smoking doesn’t change, more than 8 million people a year die from tobacco-related diseases in the forecast period.
Infrequent use of nicotine can lead to dependence as it is very addictive. Smoking cessation products such as lozenges, or patches, nicotine gum cause nicotine addiction. Worldwide, habitual use of tobacco and tobacco products continues to be a significant contributor to health problems.
To support tobacco cessation there are effective treatments that include both FDA-approved medications and behavioral therapies. Various forms of nicotine replacement therapy are included in FDA-approved pharmacotherapies as well as varenicline and bupropion. Research states that smokers who receive a combination of cessation medications and behavioral treatment quit at higher rates than the people who receive minimal intervention. Nicotine Replacement Therapy over the counter a variety of formulations of nicotine NRTs are available including the transdermal patch, gum, spray, lozenges and are effective equally for cessation. The brain receptors targeted by nicotine are stimulated by NRTs that help relieves nicotine cravings and withdrawal symptoms which leads to relapse. To get through the early stages of cessation many people use NRT, and longer-term treatment may benefit people with more severe nicotine addiction. Hence, the increasing number of Tobacco/Nicotine addiction and the availability of different treatments will drive the substance abuse treatment market.
The hospital Pharmacy segment will dominate the substance abuse treatment market
A dispensary within a hospital is a hospital pharmacy that prepares, compounds, stocks, and dispenses inpatient medications. They usually stock a large range of medications, including more investigational and specialized medications, than feasible in the community setting. Community pharmacists are placed well and be invaluable when linking secondary care services with patients. The guidelines are also relevant for allied healthcare professionals and specialist hospital-based pharmacists. They are increasingly likely to encounter drug-using patients with a wide range of physical and mental health problems.
A hospital pharmacy would be the safest place for dispensing substance abuse treatment drugs. Pharmacists are experts in medication and play a significant role in dispensing and monitoring medication to ensure safe and optimal use. Dispensing substance abuse treatment drugs like other medications through pharmacies is the safest option.
Market Geographical Landscape
North America region will dominate the substance abuse treatment market
Increasing awareness campaigns and increasing the incidence of substance abuse in this region will drive the treatment market.
In America 1 in 12 adults (18.7 million) had a substance use disorder, and 46.6 million had a mental illness. Though more than 8.5 million were found to have both a SUD and mental illness. Americans more than 16 million are living with a disease caused by smoking. In the United States, cigarette smoking is responsible for more than 480,000 deaths per year and secondhand smoke exposure includes more than 41,000 death. This is annually about one in five deaths, or 1,300 deaths every day.
The highly addictive substance nicotine is found in tobacco products. Around 50 million people in America are addicted to some tobacco products, including chewing tobacco, cigars, cigarettes, and snuff. Nicotine addiction is the most common addiction in America. According to research from the Commonwealth Fund, in 2020, overdose deaths in the United States exceeded 90,000, compared with 70,630 in 2019. The agency within the U.S. Department of Health and Human Services is the Substance Abuse and Mental Health Services Administration (SAMHSA) that leads public health efforts to advance the nation's behavioral health. Its mission is to reduce the impact of substance abuse and mental illness on America's communities.
Company and Competitive Landscape
Major key players in the substance abuse treatment market are Allergan PLC, Alkermes, Noramco, Indivior PLC, Teva Pharmaceutical Industries Ltd, Pfizer, Inc., Mallinckrodt plc, GlaxoSmithKline plc, Pharmaceuticals Ltd, and BioCorRx, Inc., CureApp Inc.
Substance Abuse Treatment Market Key Companies to Watch
CureApp Inc.
Overview: CureApp® is the leading digital health therapeutic medical device (software) company delivering an innovative solution called "prescription digital therapeutics" to medical treatment fields based on robust scientific evidence. With the recent rapid technological advances, it is becoming clear that interventions with prescription digital therapeutics in daily lives can produce remarkable therapeutic effects in various disease areas.
Product Portfolio: The company comprises Digital Healthcare, Digital Therapeutics, Medical Mobile Application, Mobile Healthcare, Behavioral Science, Self-Management, and Cognitive Behavioral Therapy.
Key Development: CureApp, Inc. has announced that CureApp SC Nicotine Addiction Treatment App and CO Checker, a treatment app targeting nicotine addiction. As of December 1, 2020, it is now covered by Japan’s public healthcare insurance system, followed by a period of clinical trials and regulatory approval.
The substance abuse treatment market report would provide access to an approx. 53 market data table, 41 figures, and 180 pages.
